Tu1880 IMPACT OF OZANIMOD (OZA) ON C-X-C MOTIF CHEMOKINE LIGAND 9 (CXCL9) LEVELS AND THE ASSOCIATION WITH OZA EFFICACY IN PATIENTS (PTS) WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE (CD): RESULTS FROM THE PHASE 2 STEPSTONE STUDY
Year: 2024
Type: conference-abstract
Source: Gastroenterology
Authors: Geert D'Haens, Jiangwei Zhang, Subrata Ghosh, Douglas C. Wolf, Brian G. Feagan, Rachel Maddux, Chun Wu, Sarah Hu, AnnKatrin Petersen, Sarah Harris
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4396632704